Global burden of hypertension: analysis of worldwide data

Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA.
The Lancet (Impact Factor: 45.22). 01/2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1
Source: PubMed

ABSTRACT Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025.
We searched the published literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles. We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples. All data were obtained independently by two investigators with a standardised protocol and data-collection form.
Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1% of women [25.5-26.6%]), and 29.2% (28.8-29.7%) were projected to have this condition by 2025 (29.0% of men [28.6-29.4%] and 29.5% of women [29.1-29.9%]). The estimated total number of adults with hypertension in 2000 was 972 million (957-987 million); 333 million (329-336 million) in economically developed countries and 639 million (625-654 million) in economically developing countries. The number of adults with hypertension in 2025 was predicted to increase by about 60% to a total of 1.56 billion (1.54-1.58 billion).
Hypertension is an important public-health challenge worldwide. Prevention, detection, treatment, and control of this condition should receive high priority.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To examine if employees with higher nutrition knowledge have better diet quality and lower prevalence of hypertension.
    12/2015; 2:105-113. DOI:10.1016/j.pmedr.2014.11.008
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to develop and characterize a wheat-based fermented rice (dosa) with potential anti-hypertensive effects using γ-aminobutyric acid (GABA)-producing Lactobacillus plantarum. Results showed that lactic acid bacterial fermentation enhanced the angiotensin converting enzyme inhibitory, radical scavenging activities and the GABA content (143 mg/kg at 120 h fermentation) of the dosa. The rats in the in-vivo trial were fed experimental diets containing dosa (T1), fermented dosa (T2) or dosa + pure GABA (T3). The systolic blood pressure, aortic endoteline-1 protein, plasma norepinephrine, serum level of thiobarbituric acid reactive substances and superoxide dismutase activity indicated improvement upon feeding of the diets containing GABA. While, the blood chemistry variables were not significantly affected in this experiment. GABA-enriched fermented dosa could therefore be considered as a functional food with the promising blood-pressure lowering effect.
    Journal of Functional Foods 06/2015; 16. DOI:10.1016/j.jff.2015.04.015 · 4.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Salt sensitivity is estimated to be present in 51% of the hypertensive and 26% of the normotensive populations. The individual blood pressure response to salt is heterogeneous and possibly related to inherited susceptibility. Although the mechanisms underlying salt sensitivity are complex and not well understood, genetics can help to determine the blood response to salt intake. So far only a few genes have been found to be associated with salt-sensitive hypertension using candidate gene association studies. The kidney is critical to overall fluid and electrolyte balance and long-term regulation of blood pressure. Thus, the pathogenesis of salt sensitivity must involve a derangement in renal NaCl handling: an inability to decrease renal sodium transport and increase sodium excretion in the face of an increase in NaCl load that could be caused by aberrant counter-regulatory natriuretic/antinatriuretic pathways. We review here the literature regarding the gene variants associated with salt-sensitive hypertension and how the presence of these gene variants influences the response to antihypertensive therapy.
    Current Hypertension Reviews 05/2015; 11(1).